WeVote

Bill

Bill

HB 1120

Hyperbaric oxygen treatment program.

2025 Regular Session Introduced by Steve Bartels and 3 co-sponsors

Indiana bill establishes hyperbaric oxygen therapy program, likely expanding veteran and patient access to treatment for wounds, poisoning, and related conditions.

Representatives Lauer and Pack R added as coauthors
0
WeVote Research Nonpartisan
Bill Summary · HB 1120

Legislative bill overview

HB 1120 establishes a hyperbaric oxygen treatment program in Indiana, likely creating a framework for providing or regulating hyperbaric oxygen therapy (HBOT) services. The bill has been referred to the Committee on Veterans Affairs and Public Safety, suggesting it may target veterans or address specific medical conditions. Details on funding, eligibility, and scope are not yet publicly available from the bill's current status.

Why is this important

Hyperbaric oxygen therapy is used to treat conditions including diabetic wounds, carbon monoxide poisoning, and certain non-healing injuries. If this bill expands access or creates state-funded HBOT programs, it could improve treatment outcomes for eligible Hoosiers while potentially increasing state healthcare expenditures. Veterans' inclusion in the committee referral suggests the legislation may address service-related conditions.

Potential points of contention

  • Funding and cost: Whether the program requires new state appropriations and whether HBOT is cost-effective compared to alternative treatments
  • Eligibility criteria: Which conditions qualify for treatment and whether coverage includes all patients or is limited to specific groups (veterans, low-income, specific diagnoses)
  • Evidence base: HBOT has strong evidence for some conditions but disputed efficacy for others, raising questions about which treatments the program will cover

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.